Monosaccharides
Medchemexpress LLC Crocetin disodium | 591230-99-8 | 99.3% | 372.37 | 100 MG
Crocetin (Transcrocetin) disodium is extracted from saffron (Crocus sativus L.) and acts as an NMDA receptor antagonist with high affinity. It is for research use only and not sold to patients.
- Extracted from saffron (Crocus sativus L.).
- Acts as an NMDA receptor antagonist.
- Exhibits high affinity.
Medchemexpress LLC NSC-87877 (disodium) | 56932-43-5 | 98.0% | 503.42 | C19H11N3Na2O7S2 | 10 MG
NSC-87877 disodium is the disodium salt form of a small-molecule inhibitor of protein tyrosine phosphatases SHP-1 and SHP-2, intended for research use in biochemical and cell-based studies. It is provided as a solid and characterized for biochemical potency and composition.
- Potent inhibitor of SHP-1 and SHP-2 (IC50 ≈ 0.318 μM and 0.355 μM).
- Provided as the disodium salt for improved solubility and handling.
- High purity (98.0%) suitable for research applications.
- Molecular weight 503.42 and formula C19H11N3Na2O7S2 for precise mass calculations.
- Available in small milligram pack sizes for screening and assay development.
Medchemexpress LLC Crocetin disodium | 591230-99-8 | MFCD22572782 | 99.3% | 372.37 g/mol | C20H22Na2O4 | 10 MG
Crocetin disodium is the disodium salt of crocetin, a carotenoid extracted from saffron (Crocus sativus L.). It acts as an ionotropic glutamate (iGluR) antagonist with high affinity for NMDA receptors and is supplied for in vitro research use.
- Acts as an NMDA (iGluR) receptor antagonist with high affinity.
- High purity, reported as 99.3%.
- Chemical formula C20H22Na2O4; molecular weight 372.37 g/mol.
- Orange to reddish-brown solid; also available as an aqueous solution (10 mM, 1 mL).
- Soluble in water (≥ 4.56 mg/mL, ~12.25 mM); insoluble or slightly soluble in DMSO (< 1 mg/mL).
- Intended for in vitro research applications.
Selleck Chemical LLC NADH Disodium Salt Hydrate
NADH is a coenzyme that functions as a regenerating electron donor in catabolic processes including glycolysis -oxidation and the citric acid cycle
Medchemexpress LLC cGAMP disodium | 2407516-83-8 | 98.5% | 718.37 | 25 MG
cGAMP disodium | 2407516-83-8 | 98.5% | 718.37 | 25 MG
Selleck Chemical LLC Fosfomycin Disodium S5048-25mg
Fosfomycin (Phosphonemycin) is a bactericidal low-molecular weight broad-spectrum antibiotic with putative activity against several bacteria including multidrug-resistant Gram-negative bacteria by irreversibly inhibiting an early stage in cell wall synthesis
Selleck Chemical LLC Eprodisate disodium S4567-100mg
Eprodisate Disodium (NC-503) is the orally available disodium salt form of Eprodisate a small-molecule orally bioavailable inhibitor of AA-amyloid fibrillogenesis
Selleck Chemical LLC Fosfomycin Disodium S5048-1g
Fosfomycin (Phosphonemycin) is a bactericidal low-molecular weight broad-spectrum antibiotic with putative activity against several bacteria including multidrug-resistant Gram-negative bacteria by irreversibly inhibiting an early stage in cell wall synthesis
Selleck Chemical LLC Clodronate Disodium S4108-50mg
Clodronate Disodium a bisphosphonate is a potent antiosteolytic agent which inhibits bone resorption
Selleck Chemical LLC Disodium Cromoglycate S1911-1g
Disodium Cromoglycate (Gynazole FPL 670 (Cromolyn) Disodium Cromolyn sodium) is an antiallergic drug with IC50 of 39 g/mL
Selleck Chemical LLC D-Glucose 6-phosphate disodium
D-Glucose 6-phosphate disodium salt is the disodium salt form of D-Glucose 6-phosphate a common form of glucose within the cell participating in two major metabolic pathways glycolysis and the pentose phosphate pathway It can be coverted to glycogen or starch for storage
TARGETMOL CHEMICALS INC Pemetrexed disodium 500MG
Also available in 1 g, 1 mL, 25 mg, 50 mg, 100 mg, 200 mg and bulk. Please contact Fisher for quotes. Pemetrexed disodium (LY-231514) is a parenterally administered folate antagonist and antineoplastic agent, used in the treatment of non-small cell lung cancer and malignant mesothelioma. Pemetrexed disodium therapy has been associated with moderate rates of serum enzyme elevations during therapy, but has not been convincingly linked to instances of acute, clinically apparent liver injury. Purity 99.92%